West Pharmaceutical Services, Inc. NYSE:WST

West Pharmaceutical Services stock price today

$246.98
-86.24
-25.88%
Financial Health
0
1
2
3
4
5
6
7
8
9

West Pharmaceutical Services stock price monthly change

+3.17%
month

West Pharmaceutical Services stock price quarterly change

+3.17%
quarter

West Pharmaceutical Services stock price yearly change

-6.37%
year

West Pharmaceutical Services key metrics

Market Cap
23.87B
Enterprise value
23.94B
P/E
48.55
EV/Sales
8.32
EV/EBITDA
32.19
Price/Sales
8.39
Price/Book
8.81
PEG ratio
3.12
EPS
7.68
Revenue
2.92B
EBITDA
811.6M
Income
568.7M
Revenue Q/Q
-2.95%
Revenue Y/Y
1.56%
Profit margin
17.37%
Oper. margin
20.02%
Gross margin
34.92%
EBIT margin
20.02%
EBITDA margin
27.71%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

West Pharmaceutical Services stock price history

West Pharmaceutical Services stock forecast

West Pharmaceutical Services financial statements

Average Price Target
Last Year

$393

Potential upside: 59.12%

Based on estimate of 1 analysts
  • Analysts Price target

  • Financials & Ratios estimates

West Pharmaceutical Services, Inc. (NYSE:WST): Profit margin
Jun 2023 753.8M 155.1M 20.58%
Sep 2023 747.4M 161.3M 21.58%
Dec 2023 732M 137M 18.72%
Mar 2024 695.4M 115.3M 16.58%
0.24%
Yield TTM
West Pharmaceutical Services, Inc. (NYSE:WST): Payout ratio
Payout ratio 11.73%
West Pharmaceutical Services, Inc. (NYSE:WST): Dividend Yield
2019 0.41%
2020 0.23%
2021 0.15%
2022 0.31%
2023 0.22%
West Pharmaceutical Services, Inc. (NYSE:WST): Debt to assets
Jun 2023 3669600000 922.9M 25.15%
Sep 2023 3754700000 886.5M 23.61%
Dec 2023 3829500000 948.5M 24.77%
Mar 2024 3602300000 921.7M 25.59%
West Pharmaceutical Services, Inc. (NYSE:WST): Cash Flow
Jun 2023 169.2M -82.1M -176.8M
Sep 2023 230.1M -95.7M -22.3M
Dec 2023 239.1M -108.8M -189.5M
Mar 2024 118.2M -90.6M -271M

West Pharmaceutical Services alternative data

West Pharmaceutical Services, Inc. (NYSE:WST): Employee count
Aug 2023 10,700
Sep 2023 10,700
Oct 2023 10,700
Nov 2023 10,700
Dec 2023 10,700
Jan 2024 10,700
Feb 2024 10,700
Mar 2024 10,600
Apr 2024 10,600
May 2024 10,600
Jun 2024 10,600
Jul 2024 10,600

West Pharmaceutical Services other data

88.87% -2.51%
of WST is owned by hedge funds
67.54M -2.18M
shares is hold by hedge funds

West Pharmaceutical Services, Inc. (NYSE:WST): Insider trades (number of shares)
Period Buy Sel
Dec 2023 0 1013
Feb 2024 0 73163
Mar 2024 0 815
May 2024 0 66000
Jun 2024 0 1800
Aug 2024 0 31761
Oct 2024 0 703
Transaction Date Insider Security Shares Price per share Total value Source
Option
WITHERSPOON CHARLES officer: VP & Treasurer
Common Stock 478 $173.22 $82,799
Sale
WITHERSPOON CHARLES officer: VP & Treasurer
Common Stock 478 $310.4 $148,371
Sale
WITHERSPOON CHARLES officer: VP & Treasurer
Common Stock 225 $310.4 $69,840
Option
WITHERSPOON CHARLES officer: VP & Treasurer
Stock Options (Right to Buy) 478 $173.22 $82,799
Option
ABRAHAM SILJI officer: SVP, Chi.. Common Stock 458 N/A N/A
Option
ABRAHAM SILJI officer: SVP, Chi.. Rst. Stock Unit 458 N/A N/A
Option
WITHERSPOON CHARLES officer: VP & Treasurer
Common Stock 529 $102.51 $54,228
Sale
WITHERSPOON CHARLES officer: VP & Treasurer
Common Stock 529 $300 $158,700
Sale
WITHERSPOON CHARLES officer: VP & Treasurer
Common Stock 500 $300 $150,000
Option
WITHERSPOON CHARLES officer: VP & Treasurer
Stock Options (Right to Buy) 529 $102.51 $54,228
Patent
Application
Filling date: 2 Mar 2022 Issue date: 8 Sep 2022
Application
Filling date: 22 Jul 2020 Issue date: 11 Aug 2022
Application
Filling date: 5 Apr 2022 Issue date: 21 Jul 2022
Application
Filling date: 14 May 2020 Issue date: 14 Jul 2022
Grant
Filling date: 15 Mar 2019 Issue date: 28 Jun 2022
Grant
Filling date: 18 Oct 2019 Issue date: 21 Jun 2022
Application
Filling date: 25 Jan 2020 Issue date: 16 Jun 2022
Grant
Filling date: 17 Dec 2018 Issue date: 10 May 2022
Grant
Filling date: 6 Nov 2020 Issue date: 12 Apr 2022
Grant
Filling date: 25 Nov 2019 Issue date: 22 Mar 2022
Friday, 20 December 2024
zacks.com
Wednesday, 11 December 2024
prnewswire.com
Sunday, 8 December 2024
seekingalpha.com
Friday, 29 November 2024
zacks.com
Tuesday, 19 November 2024
zacks.com
Friday, 15 November 2024
youtube.com
Wednesday, 6 November 2024
seekingalpha.com
Tuesday, 29 October 2024
prnewswire.com
zacks.com
Monday, 28 October 2024
zacks.com
Thursday, 24 October 2024
seekingalpha.com
benzinga.com
zacks.com
zacks.com
reuters.com
prnewswire.com
Tuesday, 22 October 2024
prnewswire.com
Monday, 21 October 2024
zacks.com
Thursday, 17 October 2024
zacks.com
Thursday, 10 October 2024
prnewswire.com
Wednesday, 9 October 2024
prnewswire.com
Monday, 7 October 2024
prnewswire.com
Thursday, 5 September 2024
prnewswire.com
Thursday, 25 July 2024
seekingalpha.com
zacks.com
zacks.com
reuters.com
prnewswire.com
Wednesday, 24 July 2024
seekingalpha.com
Tuesday, 23 July 2024
seekingalpha.com
  • What's the price of West Pharmaceutical Services stock today?

    One share of West Pharmaceutical Services stock can currently be purchased for approximately $246.98.

  • When is West Pharmaceutical Services's next earnings date?

    Unfortunately, West Pharmaceutical Services's (WST) next earnings date is currently unknown.

  • Does West Pharmaceutical Services pay dividends?

    Yes, West Pharmaceutical Services pays dividends and its trailing 12-month yield is 0.24% with 12% payout ratio. The last West Pharmaceutical Services stock dividend of $0.18 was paid on 2 Feb 2022.

  • How much money does West Pharmaceutical Services make?

    West Pharmaceutical Services has a market capitalization of 23.87B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2.18% to 2.95B US dollars.

  • What is West Pharmaceutical Services's stock symbol?

    West Pharmaceutical Services, Inc. is traded on the NYSE under the ticker symbol "WST".

  • What is West Pharmaceutical Services's primary industry?

    Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.

  • How do i buy shares of West Pharmaceutical Services?

    Shares of West Pharmaceutical Services can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are West Pharmaceutical Services's key executives?

    West Pharmaceutical Services's management team includes the following people:

    • Mr. Eric M. Green Pres, Chief Executive Officer & Director(age: 55, pay: $3,100,000)
    • Mr. Bernard J. Birkett Senior Vice President & Chief Financial Officer(age: 56, pay: $1,460,000)
    • Mr. David A. Montecalvo Senior Vice President and Chief Operations & Supply Chain Officer(age: 60, pay: $1,040,000)
    • Mr. Silji Abraham Senior Vice President & Chief Technology Officer(age: 53, pay: $1,030,000)
  • How many employees does West Pharmaceutical Services have?

    As Jul 2024, West Pharmaceutical Services employs 10,600 workers.

  • When West Pharmaceutical Services went public?

    West Pharmaceutical Services, Inc. is publicly traded company for more then 45 years since IPO on 17 Mar 1980.

  • What is West Pharmaceutical Services's official website?

    The official website for West Pharmaceutical Services is westpharma.com.

  • Where are West Pharmaceutical Services's headquarters?

    West Pharmaceutical Services is headquartered at 530 Herman O. West Drive, Exton, PA.

  • How can i contact West Pharmaceutical Services?

    West Pharmaceutical Services's mailing address is 530 Herman O. West Drive, Exton, PA and company can be reached via phone at +61 5942900.

  • What is West Pharmaceutical Services stock forecast & price target?

    Based on 1 Wall Street analysts` predicted price targets for West Pharmaceutical Services in the last 12 months, the avarage price target is $393. The average price target represents a 59.12% change from the last price of $246.98.

West Pharmaceutical Services company profile:

West Pharmaceutical Services, Inc.

westpharma.com
Exchange:

NYSE

Full time employees:

10,600

Industry:

Medical - Instruments & Supplies

Sector:

Healthcare

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

530 Herman O. West Drive
Exton, PA 19341-0645

CIK: 0000105770
ISIN: US9553061055
CUSIP: 955306105